Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9455

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 0143-9455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin For Injection 350 Cc 1)

Chemical structure diagram of daptomycin showing its detailed molecular arrangement including various rings, amide bonds, and side chains, consistent with a complex lipopeptide antibiotic structure.*

FDA Label Image

Ctn (Daptomycin For Injection 350 Cc 2)

Packaging label for Daptomycin for Injection, 350 mg per vial, lyophilized powder for intravenous infusion. The label indicates it is a prescription drug manufactured by Hikma Pharmaceuticals USA Inc. It must be refrigerated and reconstituted with 7 mL of 0.9% Sodium Chloride Injection to a final concentration of 50 mg/mL. The package contains one single-dose vial and states to discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.